Pharmacy Times

JULY 7, 2025

SHOW MORE The FDA has approved Y-90 resin microspheres (SIR-Spheres; Sirtex Medical), a radioembolization therapy for the treatment of unresectable hepatocellular carcinoma (HCC), which is marked as the most common form of liver cancer in adults residing in the US. Mayo Clinic. The DOORwaY90 study showed a 98.5% News release.

FDA 50

FDA Compounding Pharmacies Immunization Mayo Clinic 50

Pharmacy Times

JUNE 9, 2025

These treatments are already in widespread use across health systems, from Mayo Clinic’s 9 active and 5 pending to University of California (UC) San Diego Health’s 12 active and 5 under review. At Children’s Hospital of Philadelphia (CHOP), eligible patients can access 12 advanced therapeutics and 8 more in the pipeline.

Compounding Pharmacies 56

Compounding Pharmacies FDA Hospitals Immunization 56

Pharmacy Times

JULY 9, 2025

SHOW MORE FDA approves a new dosing schedule for donanemab, enhancing safety and efficacy in treating early symptomatic Alzheimer disease. This advancement provides healthcare professionals with improved confidence in managing Alzheimer's disease with donanemab.

Labelling 65

Labelling FDA Compounding Pharmacies Independent Pharmacies 65

Pharmacy Times

JUNE 26, 2025

In an interview with Pharmacy Times , Shaji Kumar, MD, consultant and research chair of the Division of Hematology in the Department of Internal Medicine at Mayo Clinic, discussed emerging data from the phase 2 RedirecTT-1 study (NCT04586426).

Compounding Pharmacies 65

Compounding Pharmacies Vaccines Immunization Mayo Clinic 65

Pharmacy Times

JULY 14, 2025

SHOW MORE FDA fast-tracks TRE-515 for advanced prostate cancer, combining it with radiation therapy to enhance treatment outcomes and patient care. The FDA has granted fast track designation to TRE-515 (Trethera Corporation), a novel drug, in combination with radiation therapy for the treatment of prostate cancer.

FDA 73

FDA Compounding Pharmacies Compounding Immunization 73

Pharmacy Times

JUNE 24, 2025

The FDA approved an autoinjector of belimumab (Benlysta; GSK) for the subcutaneous injection in children aged 5 years and older with active lupus nephritis (LN) who are receiving standard therapy. This formulation was administered in a clinical setting every 4 weeks for about an hour.

FDA 106

FDA Compounding Pharmacies Vaccines Immunization 106

Drug Topics

JUNE 24, 2025

The FDA approved belimumab (Benlysta), a 200 mg/mL autoinjection, for subcutaneous injection in patients 5 years of age and older with active lupus nephritis who are receiving standard therapy. It would be a 1-hour infusion in a hospital or clinic setting every 4 weeks, following an initial loading phase given on days 0, 14, and 28.

FDA 509

FDA Immunization Vaccines Mayo Clinic 509

Pharmacy Times

JUNE 19, 2025

Standard-of-care treatment for patients with ALK fusions is alectinib (Alecensa; Genentech), a TKI that was approved by the FDA in 2024 for adjuvant treatment following tumor resection in patients with ALK-positive NSCLC. They are more common in younger patients and are often associated with a minimal smoking history.

Chemotherapy 73

Chemotherapy Compounding Pharmacies Hospitals Immunization 73

Pharmacy Times

JUNE 15, 2025

Following, HR+, HER2- early breast cancer is a common subtype where the cancer cells have estrogen and progesterone receptors but do not have excessive amounts of the HER2 protein, according to Mayo Clinic. Mayo Clinic. Clinicaltrials.gov: NCT05306340. Updated April 15, 2025. Accessed June 13, 2025. News release.

Mayo Clinic 106

Mayo Clinic Compounding Pharmacies Immunization Compounding 106

Drug Topics

JULY 16, 2025

READ MORE: COVID-19 Hospitalizations Disproportionately Impacted Black, Hispanic Children “Resilience is the extent to which we can bounce back from adverse events, cope with stress, or succeed in the face of adversity,” said Cindy Bergeman, PhD, MS, professor of developmental psychology at the University of Notre Dame. Mayo Clinic.

Specialty Pharmacies 316

Specialty Pharmacies Independent Pharmacies Compounding Vaccines 316

Pharmacy Times

JUNE 9, 2025

Mayo Clinic. Akkooi A, Mandala M, Kicinski M, Primary analysis of the EORTC-2139-MG/Columbus-AD trial: A randomized trial of adjuvant encorafenib and binimetinib versus placebo in high-risk stage II melanoma with a BRAF-V600E/K mutation. J Clin Oncol. 43, 2025 (suppl 17; abstr LBA9500). doi:10.1200/JCO.2025.43.17_suppl.LBA9500.

Compounding Pharmacies 82

Compounding Pharmacies Immunization Mayo Clinic Compounding 82

Pharmacy Times

JULY 18, 2025

Mayo Clinic. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. JAMA Netw Open. 2025;8(7):e2520011. doi:10.1001/jamanetworkopen.2025.20011 2025.20011 2. Long-term obesity and biological aging in young adults. EuerkAlert!

Compounding Pharmacies 73

Compounding Pharmacies Compounding Immunization Mayo Clinic 73

Pharmacy Times

JULY 14, 2025

The ADVANTAGE AF trial supported the FDA approval, showing 99.7% The FDA approved a label extension for the Farapulse Pulsed Field Ablation (PFA) system (Boston Scientific) to now include approval for the system in the treatment of drug-refractory, symptomatic persistent atrial fibrillation (AF). The trial reported a 63.5%

Labelling 65

Labelling FDA Compounding Pharmacies Hospitals 65

STAT

JANUARY 8, 2024

A group of academic hospitals and technology companies will form a new nonprofit venture to oversee a nationwide network of laboratories to test artificial intelligence tools designed for use in health care. Continue to STAT+ to read the full story…

Mayo Clinic 143

Mayo Clinic Hospitals FDA 143

pharmaphorum

FEBRUARY 1, 2022

If LVEF is 40% or less a patient is considered to have heart failure with reduced ejection fraction (HFrEF), sometimes known as systolic heart failure, which is generally diagnosed in hospital. Eko says it will be submitted to the FDA for approval later his year. The study is published in The Lancet Digital Health.

Mayo Clinic 140

Mayo Clinic Hospitals FDA 140

The Checkup by Singlecare

SEPTEMBER 22, 2023

Here’s what you need to know about the new FDA-approved RSV vaccine. Those with lung disease, chronic obstructive pulmonary disease (COPD), congestive heart failure, or other underlying medical conditions can quickly develop severe respiratory illness requiring hospitalization. What is RSV? Is there a vaccine for RSV?

Vaccines 105

Vaccines Immunization Insurance FDA 105

The Checkup by Singlecare

OCTOBER 17, 2023

“One of the home remedies I recommend most often is plain honey,” says Benjamin Silver, MD , associate chair of emergency medicine at Northwell Long Island Jewish Forest Hills Hospital in Queens, New York. You should also keep in mind that the FDA doesn’t regulate or approve dietary supplements advertised to cure conditions like dry cough.

Mayo Clinic 105

Mayo Clinic FDA Hospitals 105

The Checkup by Singlecare

FEBRUARY 8, 2024

In fact, in late 2023, its manufacturer, Eli Lilly, released another brand form of tirzepatide, Zepbound , with Food and Drug Administration (FDA) approval for weight loss. Still, according to the FDA’s boxed warning , anyone with a history of MTC or a personal or family history of MEN2 should avoid it.

Labelling 98

Labelling Mayo Clinic Adverse Reactions FDA 98

The Checkup by Singlecare

NOVEMBER 9, 2023

This is a common medical condition: Sinus infections affect about 35 million Americans annually and are responsible for almost 16 million hospital visits each year. Luke’s Hospital (2005) The post 9 home remedies for sinus infections appeared first on The Checkup.

Immunization 106

Immunization Mayo Clinic Hospitals Communication 106

The Checkup by Singlecare

JANUARY 18, 2024

Drug interactions | Food interactions | Other interactions | Avoiding interactions | When to see a doctor Ozempic (semaglutide) has been the talk of the nation, more so for its use for weight loss rather than its actual Food and Drug Administration (FDA) indication, type 2 diabetes mellitus.

Mayo Clinic 52

Mayo Clinic Labelling FDA Hospitals 52

PharmaShots

JUNE 6, 2023

Regulatory Compliance: Companies must emphasize the guidelines set by the regulatory body, be it FDA or EMA, to ensure good manufacturing practices. Such collaborations are important indeed to keep up in the era of cutting-edge technology.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Mayo Clinic Data Entry 40

The Checkup by Singlecare

SEPTEMBER 28, 2023

Inhale steam “Breathing in steam hydrates dry nasal cavities and sinuses, loosening any mucus and secretions,” says Robert Glatter, MD , a board-certified emergency medicine physician at Lenox Hill Hospital in New York City. Cleveland Clinic (2022) Suctioning the Nose with a Bulb Syringe. Controlled Clinical Trial (2013) Vitamin C.

Compounding 105

Compounding Immunization Mayo Clinic Dosage 105

The Checkup by Singlecare

SEPTEMBER 15, 2023

According to the Mayo Clinic , antibiotic-induced diarrhea typically starts about a week after the first antibiotic dose. diff is highly contagious and dangerous, making it a concern among hospitalized patients. Mayo Clinic (2021) Adverse events in people taking macrolide antibiotics versus placebo for any indication.

Mayo Clinic 111

Mayo Clinic Pharmacy Program Director Labelling Hospitals 111

The Checkup by Singlecare

JANUARY 12, 2024

While Wegovy and Ozempic are produced by the same manufacturer (Novo Nordisk) and contain the same drug (semaglutide), they are prescribed at different doses and approved by the Food and Drug Administration (FDA) for different functions: Wegovy for weight management and Ozempic for the treatment of Type 2 diabetes.

Dosage 108

Dosage Mayo Clinic FDA Insurance 108

The Checkup by Singlecare

JANUARY 18, 2024

A large 18-year study found that senior patients taking Bactrim and spironolactone concurrently were at increased risk of being admitted to the hospital for very high potassium levels. a board-certified pharmacotherapy specialist based in Rochester, Minnesota.

Mayo Clinic 105

Mayo Clinic Adverse Reactions Packaging Labelling 105

pharmaphorum

DECEMBER 14, 2022

“Patients who are MRD negative have a better prognosis than patients who are MRD positive, generally, but they still relapse,” commented Mark Litzow of the Mayo Clinic, who presented the data at ASH. “It’s a huge step forward for treating this devastating disease.”

Mayo Clinic 52

Mayo Clinic Chemotherapy Labelling Hospitals 52

The Checkup by Singlecare

JANUARY 12, 2024

Sources Monoamine oxidase inhibitors (MAOIs) , Mayo Clinic (2019). The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond? Journal of hospital medicine (2010). Mayo Clinic (2022). Phenylketonuria.

Mayo Clinic 52

Mayo Clinic Communication Chemotherapy Dosage 52

The Checkup by Singlecare

JANUARY 12, 2024

“While many think that testosterone is a male-only hormone, it has a functionality for women too,” says Kecia Gaither, MD , an OB-GYN in private practice and director of perinatal services and maternal-fetal medicine at NYC Health + Hospitals in Bronx, New York. “It Yet, more than 30 FDA-approved therapies exist for men in the United States.

Mayo Clinic 52

Mayo Clinic Department of Veterans Affairs Insurance FDA 52

The Checkup by Singlecare

NOVEMBER 13, 2023

To help decrease the risk of shingles, Shingrix vaccine is FDA-approved for adults 50 and older. While there is no cure for shingles, it’s important to report it immediately to a healthcare provider to reduce the chances of associated complications. Antiviral medications such as Acyclovir ( zovirax ) and famciclovir are often prescribed.

Mayo Clinic 52

Mayo Clinic Vaccines Chemotherapy Communication 52